Latest Regulatory News

Page 424 of 631
QPM Energy Limited has launched the Isaac Energy Hub with its first stage, a 112MW gas-fired power station, aiming for mid-2027 commissioning. The company is raising $12 million to support project development and expand its integrated energy utility footprint.
Maxwell Dee
Maxwell Dee
30 June 2025
Cambium Bio has secured ethics approvals in Australia and the US to initiate pivotal Phase 3 trials of Elate Ocular, targeting moderate to severe dry eye disease, with patient dosing expected in October 2025.
Ada Torres
Ada Torres
30 June 2025
South Harz Potash Ltd has announced a pro-rata non-renounceable entitlement issue to raise approximately A$1.28 million, offering one new share for every three held plus free options. The capital raise aims to fund its dual-asset growth plans in Germany amid ongoing project development and acquisition efforts.
Maxwell Dee
Maxwell Dee
30 June 2025
Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.
Ada Torres
Ada Torres
30 June 2025
Green Critical Minerals’ McIntosh Graphite Project Pre-Feasibility Study confirms robust economics with a post-tax NPV of A$235 million and a 32.5-year mine life, underpinning plans for staged development and market entry.
Maxwell Dee
Maxwell Dee
30 June 2025
Rox Resources has completed its two-tranche placement, raising a total of $40 million to advance its Youanmi Gold Project development. The final tranche involved issuing 13.5 million shares to key institutional investors.
Maxwell Dee
Maxwell Dee
30 June 2025
Actinogen Medical has enrolled its 100th participant in the XanaMIA phase 2b/3 Alzheimer’s trial, setting the stage for a critical interim analysis in January 2026 and final results by year-end.
Ada Torres
Ada Torres
30 June 2025
ECS Botanics has launched the globally acclaimed Terphogz™ cannabis strains, including The Original Z™, into the Australian medicinal market, marking a strategic expansion of its premium product portfolio.
Ada Torres
Ada Torres
30 June 2025
Estrella Resources has confirmed a $5 million capital injection from a strategic investor exercising a tranche subscription option, underpinning its ambitious manganese and limestone projects in Timor-Leste.
Maxwell Dee
Maxwell Dee
30 June 2025
New World Resources and Central Asia Metals have agreed to increase their takeover offer to 6.2 cents per share, surpassing a competing bid and reshaping the acquisition landscape.
Maxwell Dee
Maxwell Dee
30 June 2025
Dimerix Limited has received a significant milestone payment from its Japanese partner FUSO Pharmaceutical, marking progress in the Phase 3 clinical trial of DMX-200 for kidney disease. This payment underscores the growing momentum behind Dimerix’s global licensing strategy.
Ada Torres
Ada Torres
30 June 2025
LTR Pharma has successfully completed the extractables study for its intranasal erectile dysfunction spray SPONTAN, confirming safety compliance and initiating the next phase of leachables testing to support FDA approval.
Victor Sage
Victor Sage
30 June 2025